Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash-to-Debt 0.01
NYSE:QHC's Cash-to-Debt is ranked lower than
100% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 0.37 vs. NYSE:QHC: 0.01 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:QHC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: 0.07
Current: 0.01
0
0.07
Equity-to-Asset 0.06
NYSE:QHC's Equity-to-Asset is ranked lower than
92% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. NYSE:QHC: 0.06 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:QHC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0  Med: 0.07 Max: 0.13
Current: 0.06
0
0.13
Debt-to-Equity 10.41
NYSE:QHC's Debt-to-Equity is ranked lower than
97% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 0.63 vs. NYSE:QHC: 10.41 )
Ranked among companies with meaningful Debt-to-Equity only.
NYSE:QHC' s Debt-to-Equity Range Over the Past 10 Years
Min: 4.45  Med: 8.75 Max: 76.98
Current: 10.41
4.45
76.98
Debt-to-EBITDA 43.28
NYSE:QHC's Debt-to-EBITDA is ranked lower than
97% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: 2.82 vs. NYSE:QHC: 43.28 )
Ranked among companies with meaningful Debt-to-EBITDA only.
NYSE:QHC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -7.44  Med: 0.37 Max: 43.28
Current: 43.28
-7.44
43.28
Piotroski F-Score: 6
Altman Z-Score: 0.89
Beneish M-Score: -2.95
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % -2.95
NYSE:QHC's Operating Margin % is ranked lower than
83% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. NYSE:QHC: -2.95 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:QHC' s Operating Margin % Range Over the Past 10 Years
Min: -13.36  Med: 4.85 Max: 4.93
Current: -2.95
-13.36
4.93
Net Margin % -8.59
NYSE:QHC's Net Margin % is ranked lower than
85% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 4.16 vs. NYSE:QHC: -8.59 )
Ranked among companies with meaningful Net Margin % only.
NYSE:QHC' s Net Margin % Range Over the Past 10 Years
Min: -16.26  Med: -0.39 Max: 0.36
Current: -8.59
-16.26
0.36
ROE % -96.34
NYSE:QHC's ROE % is ranked lower than
97% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. NYSE:QHC: -96.34 )
Ranked among companies with meaningful ROE % only.
NYSE:QHC' s ROE % Range Over the Past 10 Years
Min: -1804.81  Med: -129.87 Max: 270.35
Current: -96.34
-1804.81
270.35
ROA % -8.81
NYSE:QHC's ROA % is ranked lower than
86% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.45 vs. NYSE:QHC: -8.81 )
Ranked among companies with meaningful ROA % only.
NYSE:QHC' s ROA % Range Over the Past 10 Years
Min: -16.21  Med: -1.14 Max: 0.35
Current: -8.81
-16.21
0.35
ROC (Joel Greenblatt) % -5.97
NYSE:QHC's ROC (Joel Greenblatt) % is ranked lower than
82% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 14.51 vs. NYSE:QHC: -5.97 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:QHC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -25.8  Med: 9.07 Max: 12.21
Current: -5.97
-25.8
12.21
GuruFocus has detected 1 Warning Sign with Quorum Health Corp NYSE:QHC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:QHC's 30-Y Financials

Financials (Next Earnings Date: 2018-02-10 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

QHC Guru Trades in Q4 2016

David Dreman 140 sh (unchged)
Ron Baron 25 sh (unchged)
David Einhorn 2,501,800 sh (unchged)
Ronald Muhlenkamp 18,273 sh (-80.36%)
» More
Q1 2017

QHC Guru Trades in Q1 2017

Jim Simons 84,300 sh (New)
Ron Baron 25 sh (unchged)
Ronald Muhlenkamp Sold Out
David Dreman Sold Out
David Einhorn 2,170,000 sh (-13.26%)
» More
Q2 2017

QHC Guru Trades in Q2 2017

Ron Baron Sold Out
David Einhorn 1,096,991 sh (-49.45%)
Jim Simons 28,700 sh (-65.95%)
» More
Q3 2017

QHC Guru Trades in Q3 2017

Jim Simons Sold Out
David Einhorn 205,000 sh (-81.31%)
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:QHC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
David Einhorn 2017-09-30 Reduce -81.31%0.06%$2.94 - $4.91 $ 5.5036%205,000
David Einhorn 2017-06-30 Reduce -49.45%0.08%$2.72 - $5.44 $ 5.5033%1,096,991
Ron Baron 2017-06-30 Sold Out $2.72 - $5.44 $ 5.5033%0
David Einhorn 2017-03-31 Reduce -13.26%0.04%$5.34 - $9.37 $ 5.50-32%2,170,000
David Dreman 2017-03-31 Sold Out $5.34 - $9.37 $ 5.50-32%0
Ronald Muhlenkamp 2017-03-31 Sold Out 0.04%$5.34 - $9.37 $ 5.50-32%0
Ronald Muhlenkamp 2016-12-31 Reduce -80.36%0.18%$3.8 - $8 $ 5.50-9%18,273
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8361
Compare:OHEL:SILMA, BKK:VIH, BOM:540616, SGX:5WA, SGX:40T, TSXV:IOM, ATH:HYGEIA, NYSE:CCM, SGX:1D8, ISX:SRAJ, AMEX:HLTH, BKK:AHC, BKK:EKH, SGX:5NG, NZSE:ABA, BKK:M-CHAI, TSX:CHH, ATH:IASO, BKK:LPH, TSE:6099 » details
Traded in other countries:QH3.Germany,
Headquarter Location:USA
Quorum Health Corp along with its subsidiaries owns and operates hospitals. Its hospital provides services including general acute care, emergency room, general & specialty surgery, medicine, obstetrics, diagnostic, psychiatric & rehabilitation services.

Quorum Health Corp was incorporated in Delaware on July 27, 2015. The Company along with its subsidiaries owns and operates hospitals. Its hospital provides services including general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. It also provides additional outpatient services at urgent care centers, imaging centers and surgery centers.

Ratios

vs
industry
vs
history
PB Ratio 1.36
QHC's PB Ratio is ranked higher than
85% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 2.62 vs. QHC: 1.36 )
Ranked among companies with meaningful PB Ratio only.
QHC' s PB Ratio Range Over the Past 10 Years
Min: 0.42  Med: 1.02 Max: 1.48
Current: 1.36
0.42
1.48
PS Ratio 0.07
QHC's PS Ratio is ranked higher than
98% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. QHC: 0.07 )
Ranked among companies with meaningful PS Ratio only.
QHC' s PS Ratio Range Over the Past 10 Years
Min: 0.04  Med: 0.08 Max: 0.22
Current: 0.07
0.04
0.22
Price-to-Operating-Cash-Flow 7.34
QHC's Price-to-Operating-Cash-Flow is ranked higher than
55% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 14.62 vs. QHC: 7.34 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
QHC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.13  Med: 3.05 Max: 11.03
Current: 7.34
1.13
11.03
EV-to-EBIT -23.92
QHC's EV-to-EBIT is ranked lower than
99.99% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 20.85 vs. QHC: -23.92 )
Ranked among companies with meaningful EV-to-EBIT only.
QHC' s EV-to-EBIT Range Over the Past 10 Years
Min: -30.4  Med: -7.3 Max: -4.4
Current: -23.92
-30.4
-4.4
EV-to-EBITDA 48.83
QHC's EV-to-EBITDA is ranked lower than
81% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 15.17 vs. QHC: 48.83 )
Ranked among companies with meaningful EV-to-EBITDA only.
QHC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -23.6  Med: -7.5 Max: 48.98
Current: 48.83
-23.6
48.98
EV-to-Revenue 0.69
QHC's EV-to-Revenue is ranked higher than
88% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 2.18 vs. QHC: 0.69 )
Ranked among companies with meaningful EV-to-Revenue only.
QHC' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.6  Med: 0.7 Max: 0.7
Current: 0.69
0.6
0.7
Current Ratio 1.84
QHC's Current Ratio is ranked higher than
64% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.41 vs. QHC: 1.84 )
Ranked among companies with meaningful Current Ratio only.
QHC' s Current Ratio Range Over the Past 10 Years
Min: 1.59  Med: 1.84 Max: 2.52
Current: 1.84
1.59
2.52
Quick Ratio 1.68
QHC's Quick Ratio is ranked higher than
65% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.31 vs. QHC: 1.68 )
Ranked among companies with meaningful Quick Ratio only.
QHC' s Quick Ratio Range Over the Past 10 Years
Min: 1.43  Med: 1.69 Max: 2.3
Current: 1.68
1.43
2.3
Days Inventory 80.35
QHC's Days Inventory is ranked lower than
89% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 16.86 vs. QHC: 80.35 )
Ranked among companies with meaningful Days Inventory only.
QHC' s Days Inventory Range Over the Past 10 Years
Min: 42.12  Med: 83.14 Max: 86.85
Current: 80.35
42.12
86.85
Days Sales Outstanding 69.32
QHC's Days Sales Outstanding is ranked lower than
83% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 41.26 vs. QHC: 69.32 )
Ranked among companies with meaningful Days Sales Outstanding only.
QHC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 61.93  Med: 65.11 Max: 74.54
Current: 69.32
61.93
74.54
Days Payable 226.27
QHC's Days Payable is ranked higher than
87% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: 51.14 vs. QHC: 226.27 )
Ranked among companies with meaningful Days Payable only.
QHC' s Days Payable Range Over the Past 10 Years
Min: 202.35  Med: 219.18 Max: 239.46
Current: 226.27
202.35
239.46

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.93
QHC's Price-to-Median-PS-Value is ranked higher than
71% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. QHC: 0.93 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
QHC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.69  Med: 0.97 Max: 2.31
Current: 0.93
0.69
2.31
Earnings Yield (Greenblatt) % -4.19
QHC's Earnings Yield (Greenblatt) % is ranked lower than
86% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.79 vs. QHC: -4.19 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
QHC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -22.7  Med: -13.7 Max: -3.3
Current: -4.19
-22.7
-3.3

More Statistics

Revenue (TTM) (Mil) $2,072.33
EPS (TTM) $ -6.30
Short Percentage of Float12.15%
52-Week Range $2.54 - 9.46
Shares Outstanding (Mil)30.30

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 2,291 2,213 2,319
EPS ($) -1.57 -0.48 -0.01
EPS without NRI ($) -1.57 -0.48 -0.01
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAN
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyY
Less Shares Outstanding yoyY
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}